ReviewDrug safety1994
A risk-benefit assessment of carvedilol in the treatment of cardiovascular disorders.
W J Louis et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewDrug safety1994
W J Louis et al.PubMed ↗Publisher ↗
No numbers read from the abstract.